NRC at World Vaccine Congress

April 10, 2017 — April 12, 2017 — Washington, D.C. USA

NRC experts are headed to the World Vaccine Congress to showcase their research, share their insights, and connect with other leaders in the field.

Of particular interest this year is the production of viral vectors, essential tools in the hot fields of gene and cell therapy, using NRC’s proprietary HEK293 production system.

We invite you to connect with our experts during their talks and poster presentations.

NRC Expert Where to connect with them

Lakshmi Krishnan, Program leader
Vaccines and immunotherapeutics
Telephone: 613-991-3210
Email: Lakshmi.Krishnan@nrc-cnrc.gc.ca
LinkedIn: Lakshmi Krishnan

Oral presentation: Semi-synthetic archaeal lipid adjuvants as platforms for induction of cell-mediated immunity to vaccines

Tuesday April 11, 2017 at 3:25 p.m. – Bioprocessing and manufacturing track

Rénald Gilbert, Team leader
Viral vector production
Telephone: 514-496-5308
Email: Rénald.Gilbert@cnrc-nrc.gc.ca
LinkedIn: Rénald Gilbert

Oral presentation: Process development for the production of vaccines and viral vectors in suspension culture of HEK293 cells

Tuesday April 11, 2017 at 3:10 p.m. – Bioprocessing and manufacturing track

Aziza Manceur, Research officer
Immunology and cell culture scale-up
Telephone: 6514-496-6178
Email: Aziza.Manceur@cnrc-nrc.gc.ca
LinkedIn: Aziza Manceur

Poster 6: Adding insulin to increase influenza virus yield in HEK293 cells for vaccine production

Monday April 10, 2017 at 12:00 p.m.
Tuesday April 11, 2017 at 12:00 p.m.
Wednesday April 12, 2017 at 12:00 p.m.